Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
Monoclonal antibody (mAb) manufacturing must continually improve to keep up with increasing demands. To do this, biomanufacturers can deploy machine learning tools to augment traditional process ...
Existing frameworks like the U.S. Environmental Protection Agency’s Energy Star Portfolio Manager provide useful performance ...
Abstract The prevalence of multiple sexual partners (MSPs) remains high worldwide, with sub-Saharan Africa reporting some of ...
Wearables, Mobile Health (m-Health), Real-Time Monitoring Share and Cite: Alqarni, A. (2025) Analysis of Decision Support ...
WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...
Hyatt’s technicals maintain its bullish signals after rebounding from its most recent low of $134. It now trades above the 50 ...
CoinsPaid, a crypto payment ecosystem for businesses, has published a comprehensive report analyzing 41 European countries ...
A career in quantitative trading or research is one of the most exciting and intellectually rewarding paths in finance.
Amazon's Q3 earnings beat forecasts, but AWS growth lags rivals. Click here to know why analysts remain bullish and when to ...
Background Stroke after transcatheter aortic valve implantation (TAVI) is an infrequent but serious complication with ...
Medical device makers use AI to turn EU regulatory challenges into competitive advantages via supply chain optimization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results